Carbopol® 1342 NF Polymer

Applicable synonyms for Carbopol® 1342 NF Polymer: carbomer, carboxypolymethylene 
Polymerization/Residual solvent: Benzene

Key features: 

  • Emulsifier

Additional features:

  • Thickener/rheology modifier
  • Bioadhesive agent
  • Suspension & emulsion stabilizer

Recommended for use in the following dosage forms:

Recommended for use in the following markets / routes of administration:

Carbopol® 1342 NF polymer meets the limits cited in the current edition of the following monographs: 

  • United States Pharmacopeia/National Formulary (USP/NF) monograph for Carbomer 1342

Usage levels: 

  • Topical emulsion: 0.2-0.4 wt%
  • Other topical: 0.5-3 wt%

Note on toxicity testing:

The toxicity of carbomers has been summarized by the Cosmetic Ingredient Review Expert Panel in their assessment of the safety of the carbomers for cosmetic ingredients. This assessment and subsequent toxicology testing have demonstrated a low toxicity and irritation potential. Lubrizol has supporting data for dermal, ocular, and oral toxicology testing for Carbopol 1342 NF polymer. Bulletin 2 provides a summary of all toxicology studies for Lubrizol’s pharmaceutical grade polymers.

Additionally, Lubrizol has filed a Type V DMF with FDA. A letter of authorization (LOA) can be issued for FDA drug applications.

Recommended Retest Date 2 years after manufacturing date
Recommended Storage In airtight containers, protected from moisture and excessive temperature

 
 

 

Need More Information?

 Contact Us

Safety Data Sheet

SDS